| 1 | STAT6 expression in glioblastoma promotes invasive gr owth. (21595984) | Merk B.C.... Hussaini I.M. | 2011 | STAT6 |
| 2 | MEK-ERK signaling dictates DNA-repair gene MGMT expres sion and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p5 3 axis. (21957016) | Sato A.... Kitanaka C. | 2011 | MDM2, MGMT |
| 3 | PTPIP51, a positive modulator of the MAPK/Erk pathway , is upregulated in glioblastoma and interacts with 14-3-3I^ and PTP1B in situ. (21972092) | Petri M.K.... Wimmer M. | 2011 | PTPN1, YWHAB, RMDN3 |
| 4 | GM-CSF production by glioblastoma cells has a functio nal role in eosinophil survival, activation, and growth factor production for e nhanced tumor cell proliferation. (21705618) | Curran C.S.... Bertics P.J. | 2011 | CSF2 |
| 5 | Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. (22013079) | Liu Y.... Tso C.L. | 2011 | EDNRB, EDN3 |
| 6 | Glioblastoma with PNET-like components has a higher fr equency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better progno sis than primary glioblastoma. (22076165) | Song X.... Li J.Y. | 2011 | IDH1 |
| 7 | Knockdown of STAT3 expression by RNAi suppresses grow th and induces apoptosis and differentiation in glioblastoma stem cells. (20514402) | Li G.H.... Wang D.L. | 2010 | STAT3, MBP, GFAP |
| 8 | Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist. (18992284) | Martin S.... Dontenwill M. | 2009 | ITGB1, ITGA5, CAV1 |
| 9 | Genetic epidemiology of glioblastoma multiforme: conf irmatory and new findings from analyses of human leukocyte antigen alleles and motifs. (19774073) | Song W.... Tang J. | 2009 | HLA-A, HLA-C, HLA-B |
| 10 | Association between MGMT promoter hypermethylation an d p53 mutation in glioblastoma. (19544111) | Shamsara J.... Behravan J. | 2009 | TP53, MGMT |
| 11 | Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. (19212671) | Komatani H.... Shigemori M. | 2009 | CXCL12 |
| 12 | LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. (19127268) | Fuh B.... Lin J. | 2009 | CASP3, STAT3, PARP1 |
| 13 | Loss of cardiolipin in palmitate-treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis. (18182042) | Buratta M.... Corazzi L. | 2008 | CASP3, SMPD1, AIFM1 |
| 14 | HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. (17975708) | Bassi R.... Riboni L. | 2008 | AGER, HMGB1 |
| 15 | Long-term survival with glioblastoma multiforme. (17785346) | Krex D.... Schackert G. | 2007 | MGMT |
| 16 | Transcriptional upregulation of human cathepsin L by VEGF in glioblastoma cells. (17574778) | Keerthivasan S.... Chauhan S.S. | 2007 | VEGFA, CTSL1 |
| 17 | Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme. (17048097) | Martinez R.... Esteller M. | 2007 | DAPK1, TIMP2, SMARCA4 |
| 18 | Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53. (17206472) | Clark A.J.... Broaddus W.C. | 2007 | TP53, WT1 |
| 19 | Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma. (17551147) | Ren B.... Luo J.H. | 2007 | ITGA7 |
| 20 | Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54(p53wt) and U251(p53mut) glioblastoma cell lines. (17127074) | Cimmino G.... Quesada P. | 2007 | TP53, PARP1, TOP1 |
| 21 | Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. (17616812) | Zhang R.... Ray S.K. | 2007 | PTEN, CASP3, PIK3CG |
| 22 | A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. (17090523) | Liu F.... Johnson M.D. | 2006 | EPHA2 |
| 23 | A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. (17178866) | Goldberg L.... Kloog Y. | 2006 | RAC1, RHOA |
| 24 | Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. (16627485) | Kishi Y.... Arai H. | 2006 | ENPP2, LPAR1 |
| 25 | Genetic pathways to glioblastomas. (15822813) | Ohgaki H. | 2005 | TP53, PTEN, CDKN2A |
| 26 | Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma. (15893739) | Hanissian S.H.... Robertson J.H. | 2005 | MLF1, NES, MLF1IP |
| 27 | Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. (16106218) | Van Brocklyn J.R.... Prior T.W. | 2005 | SPHK1, S1PR3, S1PR2 |
| 28 | Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. (15800333) | Lefranc F.... Kiss R. | 2005 | PIK3CA, MTOR |
| 29 | hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. (16175187) | Masi A.... Arcangeli A. | 2005 | VEGFA, SPON1 |
| 30 | ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. (15509542) | Kodama T.... Okada Y. | 2004 | EGF, ADAM12, HBEGF |
| 31 | Measurement of tamoxifen-induced apoptosis in glioblastoma by cytometric bead analysis of active caspase-3. (15072442) | Zartman J.K.... Fleitz J.M. | 2004 | CASP3, ANXA5 |
| 32 | Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. (14603439) | Pandita A.... James C.D. | 2004 | EGFR |
| 33 | Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels. (12823036) | Kleinschmidt-DeMasters B.K.... Shroyer K.R. | 2003 | BIRC5 |
| 34 | Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases. (11932042) | Nagashima G.... Fujimoto T. | 2002 | MMP2, GFAP |
| 35 | Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression. (12416540) | Simon M.... Schramm J. | 2002 | CDKN2A |
| 36 | Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme. (11432670) | Romeike B.F.... Urbschat S.M. | 2001 | EGFR |
| 37 | Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines. (11517969) | Sasaki A.... Nakazato Y. | 2001 | IL6, IL1B, IL8 |
| 38 | Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. (11433397) | Hamasuna R.... Koono M. | 2001 | SPINT2, HGFAC |
| 39 | Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. (10741723) | Lund E.L.... Kristjansen P.E. | 2000 | ANGPT2, ANGPT1 |
| 40 | Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1). (11100820) | Tanabe T.... Torres B.A. | 2000 | CDK2, IFNA1 |
| 41 | Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. (11156378) | Kondraganti S.... Rao J.S. | 2000 | MMP9 |
| 42 | MGMT- and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas. (9988132) | Kirches E.... Dietzmann K. | 1999 | CYP1A2, CYP3A4, MGMT |
| 43 | PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. (9690672) | Tohma Y.... Ohgaki H. | 1998 | PTEN |
| 44 | Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. (9217971) | Gratas C.... Ohgaki H. | 1997 | FAS, FASLG |
| 45 | Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains. (9096379) | O'Rourke D.M.... Greene M.I. | 1997 | EGFR |
| 46 | p53 mutations versus EGF receptor expression in giant cell glioblastomas. (9370234) | Peraud A.... Ohgaki H. | 1997 | EGFR, TP53, MDM2 |
| 47 | Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. (9816263) | Begemann M.... Weinstein I.B. | 1996 | DYT10 |
| 48 | Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. (8922052) | Tachibana O.... Ohgaki H. | 1996 | FAS |
| 49 | Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells. (8500113) | Ruffini P.A.... Parmiani G. | 1993 | BMP6 |
| 50 | Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors. (2064311) | Bilzer T.... Keiditsch E. | 1991 | S100B, VIM |
